Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement

About this update from Corvex, Inc.

[{"type":"text","content":"PLEASANTON, Calif., Nov. 29, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company's commercial sales goals driving over $1 million in orders through the Thanksgiving Holiday.\n\n \n \n \n \n \n \n\n \n\"We were very pleased to see the exceptional conversion rates for the Evie Ring, following our strategic lead generation campaign,\" said CEO John Mastrototaro. \"We successfully leveraged an engaged community and a targeted media approach, which drove an excellent launch result.\"\nThis achievement is further underscored by the Evie Ring's previous prestigious \"Best Of\" CES 2023 acclaim from leading publications such as CNN Underscored, USA Today, Wired, Digital Trends and The Wall Street Journal Gear & Gadgets.\nAdditionally, in a landmark advancement, Movano Health is spearheading innovation in blood pressure measurement technology, recently attaining what is considered the 'holy grail' in the field: accurate cuffless and continuous blood pressure monitoring. This groundbreaking technology represents a giant leap in the proactive management of blood-pressure related cardiovascular events, such as heart attacks, the foremost cause of mortality in America.\nMovano Health's cuffless prototype recently demonstrated a level of accuracy within the standards recognized by the FDA for blood pressure monitoring devices. The prototype achieved an overall mean absolute difference (MAD) of 5.9 mmHg, which is below the 7 mmHg MAD required per a standard for wearable, cuffless blood pressure measuring devices (IEEE1708a-2019). The Company is also evaluating AI-based individual calibration methods to further enhance the future performance of the device. \nThe realization of this advancement in technology is the culmination of five years of intensive research and development, leading to 23 issued patents and 31 pending. These innovations center on advanced mmWave Radio Frequency (RF) and AI technology. Movano Health's ultra-compact System-on-a-Chip (SoC), measuring just 4 x 6.7mm, is at the forefront of industry standards for continuous, cuffless blood pressure monitoring, enhancing signal-to-noise ratio and surpassing FDA standards in a recent clinical study.\nFurthermor...

More updates from Corvex, Inc.